Chan Lee is the General Counsel of BeiGene. He previously worked at Sanofi, where he served as North America General Counsel and Head of Legal for the Specialty Care Global Business Unit, responsible for the legal oversight of the company’s U.S. and Canada businesses and its global Specialty Care business. Prior to Sanofi, he held roles of increasing responsibility at Pfizer, most notably as Chief Counsel for Pfizer’s Innovative Health global business, and, earlier, as Chief Counsel for the Vaccines, Oncology and Consumer Health global businesses, and as Assistant General Counsel for Asia. Mr. Lee earned his J.D. from the University of California at Berkeley and his B.S. in applied economics from Cornell University.